Icu Medical (ICUI) EBIT (2009 - 2026)

Icu Medical has reported EBIT for 18 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 5.36% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $43.5 million (down 34.56% YoY), and the FY2025 full-year result was $42.8 million, changed 0.31% from the prior year.
• EBIT for Q1 2026 stood at $13.6 million, up from $5.6 million in the prior quarter.
• The five-year high for EBIT was $37.7 million in Q4 2024, with the low at -$42.2 million in Q1 2022.
• Historically, EBIT has averaged $4.7 million across 5 years, with a median of $7.7 million in 2024.
• The largest YoY upside for EBIT was 5850.0% in 2023 against a maximum downside of 5387.84% in 2023.
• Icu Medical's EBIT stood at -$222000.0 in 2022, then slumped by 5387.84% to -$12.2 million in 2023, then surged by 409.37% to $37.7 million in 2024, then sank by 85.05% to $5.6 million in 2025, then soared by 140.98% to $13.6 million in 2026.
• The last three EBIT figures came in at $13.6 million (Q1 2026), $5.6 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.